4-168878257-G-C

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The ENST00000507735.6(PALLD):​c.366G>C​(p.Gln122His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000819 in 1,524,610 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q122R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0012 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00077 ( 7 hom. )

Consequence

PALLD
ENST00000507735.6 missense

Scores

15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.114

Publications

2 publications found
Variant links:
Genes affected
PALLD (HGNC:17068): (palladin, cytoskeletal associated protein) This gene encodes a cytoskeletal protein that is required for organizing the actin cytoskeleton. The protein is a component of actin-containing microfilaments, and it is involved in the control of cell shape, adhesion, and contraction. Polymorphisms in this gene are associated with a susceptibility to pancreatic cancer type 1, and also with a risk for myocardial infarction. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
CBR4 (HGNC:25891): (carbonyl reductase 4) Enables several functions, including 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity; NADPH binding activity; and NADPH dehydrogenase (quinone) activity. Involved in fatty acid biosynthetic process; glycoside metabolic process; and protein tetramerization. Located in mitochondrial matrix. Part of oxidoreductase complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0038834214).
BP6
Variant 4-168878257-G-C is Benign according to our data. Variant chr4-168878257-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 136005.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 186 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000507735.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PALLD
NM_001166108.2
MANE Select
c.1965-12665G>C
intron
N/ANP_001159580.1
PALLD
NM_001166110.2
c.366G>Cp.Gln122His
missense
Exon 2 of 12NP_001159582.1
PALLD
NM_016081.4
c.1965-12665G>C
intron
N/ANP_057165.3

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PALLD
ENST00000507735.6
TSL:1
c.366G>Cp.Gln122His
missense
Exon 2 of 12ENSP00000424016.1
PALLD
ENST00000505667.6
TSL:1 MANE Select
c.1965-12665G>C
intron
N/AENSP00000425556.1
PALLD
ENST00000261509.10
TSL:1
c.1965-12665G>C
intron
N/AENSP00000261509.6

Frequencies

GnomAD3 genomes
AF:
0.00121
AC:
184
AN:
151878
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00485
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.000194
Gnomad SAS
AF:
0.00125
Gnomad FIN
AF:
0.00388
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000750
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00261
AC:
314
AN:
120220
AF XY:
0.00197
show subpopulations
Gnomad AFR exome
AF:
0.000217
Gnomad AMR exome
AF:
0.0105
Gnomad ASJ exome
AF:
0.000514
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00412
Gnomad NFE exome
AF:
0.000535
Gnomad OTH exome
AF:
0.00162
GnomAD4 exome
AF:
0.000774
AC:
1063
AN:
1372626
Hom.:
7
Cov.:
46
AF XY:
0.000753
AC XY:
510
AN XY:
677194
show subpopulations
African (AFR)
AF:
0.0000662
AC:
2
AN:
30208
American (AMR)
AF:
0.0107
AC:
374
AN:
35008
Ashkenazi Jewish (ASJ)
AF:
0.000484
AC:
12
AN:
24816
East Asian (EAS)
AF:
0.000231
AC:
8
AN:
34636
South Asian (SAS)
AF:
0.000732
AC:
57
AN:
77860
European-Finnish (FIN)
AF:
0.00577
AC:
193
AN:
33434
Middle Eastern (MID)
AF:
0.000461
AC:
2
AN:
4334
European-Non Finnish (NFE)
AF:
0.000328
AC:
353
AN:
1074964
Other (OTH)
AF:
0.00108
AC:
62
AN:
57366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
84
168
251
335
419
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00122
AC:
186
AN:
151984
Hom.:
0
Cov.:
32
AF XY:
0.00112
AC XY:
83
AN XY:
74306
show subpopulations
African (AFR)
AF:
0.000121
AC:
5
AN:
41458
American (AMR)
AF:
0.00497
AC:
76
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.000195
AC:
1
AN:
5126
South Asian (SAS)
AF:
0.00125
AC:
6
AN:
4810
European-Finnish (FIN)
AF:
0.00388
AC:
41
AN:
10574
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
288
European-Non Finnish (NFE)
AF:
0.000751
AC:
51
AN:
67954
Other (OTH)
AF:
0.00237
AC:
5
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
8
15
23
30
38
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00136
Hom.:
0
Bravo
AF:
0.00146
ExAC
AF:
0.000531
AC:
11
Asia WGS
AF:
0.00145
AC:
5
AN:
3468

ClinVar

ClinVar submissions as Germline

Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
2
Pancreatic cancer, susceptibility to, 1 (2)
-
-
1
not specified (1)
-
-
1
Pancreatic adenocarcinoma (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
0.83
DANN
Benign
0.58
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.023
N
LIST_S2
Benign
0.41
T
M_CAP
Benign
0.014
T
MetaRNN
Benign
0.0039
T
MetaSVM
Benign
-1.0
T
PhyloP100
0.11
PROVEAN
Benign
-0.58
N
REVEL
Benign
0.041
Sift
Benign
0.034
D
Sift4G
Benign
0.27
T
Vest4
0.067
MVP
0.17
ClinPred
0.0021
T
GERP RS
0.15
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs535155432; hg19: chr4-169799408; API